|
COIL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.65960603435178E-13 |
| Normal-vs-Stage2 |
3.07009999978014E-07 |
| Normal-vs-Stage3 |
2.22044604925031E-16 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
6.153000E-01 |
| Stage1-vs-Stage3 |
1.124090E-02 |
| Stage1-vs-Stage4 |
1.5115199999971E-05 |
| Stage2-vs-Stage3 |
2.374300E-02 |
| Stage2-vs-Stage4 |
5.950600E-04 |
| Stage3-vs-Stage4 |
5.894100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.6516000000143E-06 |
| Normal-vs-Asian |
1.17409999500495E-08 |
| Caucasian-vs-AfricanAmerican |
6.630800E-01 |
| Caucasian-vs-Asian |
2.647600E-01 |
| AfricanAmerican-vs-Asian |
7.303000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77635683940025E-15 |
| Normal-vs-Female |
1.62536650805123E-12 |
| Male-vs-Female |
4.613000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.16888745746746E-12 |
| Normal-vs-Age(41-60Yrs) |
2.89768209427166E-14 |
| Normal-vs-Age(61-80Yrs) |
1.6304735339645E-12 |
| Normal-vs-Age(81-100Yrs) |
3.83980000000506E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.344200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.356200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.547600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.020800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.156800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.373000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.31960000000031E-05 |
| Classical-VS-Follicular |
5.129600E-01 |
| Classical-VS-Other |
7.882600E-01 |
| Classical-VS-Normal |
1.62614366416847E-12 |
| Tall-VS-Follicular |
1.440530E-04 |
| Tall-VS-Other |
3.369400E-01 |
| Tall-VS-Normal |
1.62547753035369E-12 |
| Follicular-VS-Other |
6.711800E-01 |
| Follicular-VS-Normal |
2.41269999534666E-08 |
| Other-VS-Normal |
2.684200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.44071429733594E-12 |
| Normal-vs-N1 |
3.19111403968009E-12 |
| N0-vs-N1 |
7.249700E-02 |
|
|
